REGENERON PHARMACEUTICALS INC·4

Dec 17, 4:18 PM ET

ROBERTS WILLIAM 4

4 · REGENERON PHARMACEUTICALS INC · Filed Dec 17, 2012

Insider Transaction Report

Form 4
Period: 2012-12-14
ROBERTS WILLIAM
VP Regul Devel & Clin Safety
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2012-12-14+30,00030,000 total
    Exercise: $179.13Exp: 2022-12-14Common Stock (30,000 underlying)
Footnotes (2)
  • [F1]The stock option award vests in four equal annual installments, commencing one year after the date of grant.
  • [F2]Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT